{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:49:58Z","timestamp":1793015398848,"version":"4.5.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2010,12,30]],"date-time":"2010-12-30T00:00:00Z","timestamp":1293667200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0015725","type":"journal-article","created":{"date-parts":[[2010,12,30]],"date-time":"2010-12-30T21:37:56Z","timestamp":1293745076000},"page":"e15725","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":94,"title":["A\u03b240 Oligomers Identified as a Potential Biomarker for the Diagnosis of Alzheimer's Disease"],"prefix":"10.1371","volume":"5","author":[{"given":"Carol Man","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice Y.","family":"Yam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Magdangal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cleo","family":"Salisbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Peretz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald N.","family":"Zuckermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Minthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph P.","family":"Fedynyshyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Allauzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,12,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study.","volume":"366","author":"CP Ferri","year":"2005","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/s00109-003-0464-5","article-title":"Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution.","volume":"81","author":"M Stefani","year":"2003","journal-title":"J Mol Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide.","volume":"8","author":"C Haass","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nature05290","article-title":"A century-old debate on protein aggregation and neurodegeneration enters the clinic.","volume":"443","author":"PT Lansbury","year":"2006","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1586\/erd.09.35","article-title":"Quantitative evaluation of Alzheimer's disease.","volume":"6","author":"A Caroli","year":"2009","journal-title":"Expert Rev Med Devices"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2174\/157488909789104839","article-title":"New perspectives for the diagnosis of Alzheimer's disease.","volume":"4","author":"L Urbanelli","year":"2009","journal-title":"Recent Pat CNS Drug Discov"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","article-title":"A specific amyloid-beta protein assembly in the brain impairs memory.","volume":"440","author":"S Lesne","year":"2006","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.","volume":"14","author":"GM Shankar","year":"2008","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1471-4159.2001.00592.x","article-title":"Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies.","volume":"79","author":"MP Lambert","year":"2001","journal-title":"J Neurochem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1523\/JNEUROSCI.5161-07.2008","article-title":"Amyloid beta protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization.","volume":"28","author":"I Klyubin","year":"2008","journal-title":"J Neurosci"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"7013","DOI":"10.1074\/jbc.270.13.7013","article-title":"Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).","volume":"270","author":"SA Gravina","year":"1995","journal-title":"J Biol Chem"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0896-6273(94)90458-8","article-title":"Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).","volume":"13","author":"T Iwatsubo","year":"1994","journal-title":"Neuron"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","article-title":"A beta oligomers - a decade of discovery.","volume":"101","author":"DM Walsh","year":"2007","journal-title":"J Neurochem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nm0197-67","article-title":"Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice.","volume":"3","author":"M Citron","year":"1997","journal-title":"Nat Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature05695","article-title":"Atomic structures of amyloid cross-beta spines reveal varied steric zippers.","volume":"447","author":"MR Sawaya","year":"2007","journal-title":"Nature"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/jnr.21353","article-title":"The use of conformation-specific ligands and assays to dissect the molecular mechanisms of neurodegenerative diseases.","volume":"85","author":"SR Leliveld","year":"2007","journal-title":"J Neurosci Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.","volume":"300","author":"R Kayed","year":"2003","journal-title":"Science"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1326-2-18","article-title":"Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers.","volume":"2","author":"R Kayed","year":"2007","journal-title":"Mol Neurodegener"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"11551","DOI":"10.1073\/pnas.0704260104","article-title":"Characterization of prion protein (PrP)-derived peptides that discriminate full-length PrPSc from PrPC.","volume":"104","author":"AL Lau","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/nm0798-832","article-title":"Detection of single amyloid beta-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy.","volume":"4","author":"M Pitschke","year":"1998","journal-title":"Nat Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1073\/pnas.0409336102","article-title":"Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease.","volume":"102","author":"DG Georganopoulou","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref22","article-title":"High-molecular-weight {beta}-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients.","author":"H Fukumoto","year":"2010","journal-title":"Faseb J"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1471-4159.2005.03407.x","article-title":"Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.","volume":"95","author":"S Barghorn","year":"2005","journal-title":"J Neurochem"},{"key":"ref24","first-page":"xxix, 567","article-title":"Diagnostic and statistical manual of mental disorders: DSM-III-R.","year":"1987"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.","volume":"34","author":"G McKhann","year":"1984","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1074-5521(00)00130-7","article-title":"Improving SH3 domain ligand selectivity using a non-natural scaffold.","volume":"7","author":"JT Nguyen","year":"2000","journal-title":"Chem Biol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"9367","DOI":"10.1073\/pnas.89.20.9367","article-title":"Peptoids: a modular approach to drug discovery.","volume":"89","author":"RJ Simon","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","article-title":"Cerebrospinal fluid and plasma biomarkers in Alzheimer disease.","volume":"6","author":"K Blennow","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archneur.60.8.1119","article-title":"Alzheimer disease in the US population: prevalence estimates using the 2000 census.","volume":"60","author":"LE Hebert","year":"2003","journal-title":"Arch Neurol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1179\/016164103101202057","article-title":"Cerebral amyloid angiopathy: pathogenesis and effects on the ageing and Alzheimer brain.","volume":"25","author":"RO Weller","year":"2003","journal-title":"Neurol Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00401-006-0054-z","article-title":"Differential deposition of amyloid beta peptides in cerebral amyloid angiopathy associated with Alzheimer's disease and vascular dementia.","volume":"111","author":"M Haglund","year":"2006","journal-title":"Acta Neuropathol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000285518","article-title":"Prevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseases.","volume":"7","author":"KA Jellinger","year":"2010","journal-title":"Neurodegener Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jns.2004.11.018","article-title":"Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease.","volume":"229\u2013230","author":"KA Jellinger","year":"2005","journal-title":"J Neurol Sci"},{"key":"ref34","article-title":"Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease.","author":"E Portelius","year":"2010","journal-title":"Acta Neuropathol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1021\/bi00069a001","article-title":"The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease.","volume":"32","author":"JT Jarrett","year":"1993","journal-title":"Biochemistry"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"32895","DOI":"10.1074\/jbc.M109.000208","article-title":"Isolation and characterization of patient-derived, toxic, high mass amyloid beta-protein (Abeta) assembly from Alzheimer disease brains.","volume":"284","author":"A Noguchi","year":"2009","journal-title":"J Biol Chem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1073\/pnas.1237107100","article-title":"Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I\/glycogen synthase kinase-3beta.","volume":"100","author":"M Hoshi","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.brainres.2009.05.035","article-title":"Validation of Abeta1-40 administration into mouse cerebroventricles as an animal model for Alzheimer disease.","volume":"1280","author":"S Takeda","year":"2009","journal-title":"Brain Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0015725","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T12:38:47Z","timestamp":1559911127000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0015725"}},"subtitle":[],"editor":[{"given":"Sergio T.","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,12,30]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2010,12,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0015725","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,30]]}}}